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Summary: Purpose: Very little is known about short-term
mortality after acute symptomatic seizure. One study found
an increased mortality in the first year after acute symp-
tomatic seizure, like mortality following acute symptomatic sta-
tus epilepticus.
Methods: We studied mortality in the first 30 days after
an acute symptomatic seizure in two cohorts. In Washington
Heights, New York City, we reviewed the medical records of
all adults aged 20 years and older seen at Columbia Presby-
terian Medical Center from January 1, 1990 through Decem-
ber 13, 1994 to identify incident acute symptomatic seizure.
In Rochester, Minnesota, the medical records of all Rochester
residents were reviewed to identify incident acute symptomatic
seizure from January 1, 1965 through December 31, 1984. Case
fatality (CF) and standardized mortality ratio (SMR) were cal-
culated for deaths in the first 30 days.
Results: A total of 323 adults were identified in Washington
Heights and 428 in Rochester. The CF was 20% in both cohorts.
CF was greatly increased in the people aged 65 years and older
(28.4% in Washington Heights and 40.5% in Rochester) versus
younger individuals (17.7% in Washington Heights and 11.2% in
Rochester). In both cohorts, the SMR was greatly increased over-
all (102.1 in Washington Heights and 149.4 in Rochester), and
separately for males, females, all etiologies except head trauma
in Washington Heights, and younger individuals. In older indi-
viduals, the SMR was increased in Washington Heights but not
in Rochester.
Conclusion: Acute symptomatic seizures are associated with
increased mortality in the first 30 days. It is unknown how
seizures contribute to this mortality or whether mortality is due
solely to the underlying medical condition. Key Words: Acute
symptomatic seizure—Mortality.
Very little is known about mortality following an acute
symptomatic seizure. One study in Bordeaux (1) found
that mortality was increased in the first year follow-
ing an acute symptomatic seizure (SMR = 10.3, 95%
CI 8.3–12.7). Data on mortality following acute symp-
tomatic status epilepticus also show an increased mortality
(2–6).
METHODS
We undertook a study of mortality in the first 30 days
after an acute symptomatic seizure in two cohorts: a
multiethnic population from Washington Heights, New
York; and an ethnically homogeneous population from
Rochester, Minnesota. Acute symptomatic seizures were
defined as a seizure in “close” temporal association with
an acute CNS insult or transient systemic disturbance (7).
These seizures were presumed to be an acute manifestation
of the insult. Insults included CNS infection, cerebrovas-
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cular disease, brain trauma, primary or metastatic CNS
tumor, eclampsia, acute toxic insults, alcohol or drug with-
drawal, metabolic disorders, encephalopathy, “unknown”
cause (extremely ill people with electrolyte imbalances),
and two or more causes (e.g., uremia and hypocalcemia).
Washington Heights Cohort
To identify cases with incident acute symptomatic
seizures, we reviewed the medical records of all adults
aged 20 years and older seen at Columbia Presbyterian
Medical Center with an ICD-9 discharge diagnosis indi-
cating seizure or status epilepticus (780.3, 345.0–345.9).
Patients were ascertained over the period January 1, 1990
through December 13, 1994.
Rochester, Minnesota Cohort
The medical records of all Rochester, Minnesota, resi-
dents with a diagnosis of seizure, convulsion, epilepsy, or
conditions known to be related to seizures were reviewed
in order to ascertain patients with incident acute symp-
tomatic seizures (7). Patients were ascertained through
the records-linkage system of the Rochester Epidemio-
logic Project from January 1, 1965 through December 31,
1984.
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TABLE 1. Distribution of cause of seizures among deaths in
the first 30 days following acute symptomatic seizure in
Washington Heights, New York City and Rochester, Minnesota
Proportion Proportion
of deaths (%) of deaths (%)
in Washington in Rochester
Heights (68 deaths in (82 deaths in
Cause of seizure the first 30 days) the first 30 days)
Cerebrovascular disease 26.4 31.7
Encephalopathic 19.2 23.2
Metabolic 26.4 8.5





2+ causes – 4.9
Analysis
We calculated the overall case fatality (CF) for death in
the first 30 days following acute symptomatic seizure and
by gender and age.
We calculated the proportion of deaths by etiology of the
acute symptomatic seizure, separately for the two cohorts.
The standardized mortality ratio (SMR) was used to
compare the observed deaths to those expected. The stan-
dard for the SMR were the death rates in the U.S. popula-
tion for 1990 for the Washington Heights cohort and the
death rates in Southeastern Minnesota for 1969 and 1979
for the Rochester cohort.
RESULTS
A total of 323 adults with an incident acute symptomatic
seizure were identified in Washington Heights, New York
City, and 428 cases in Rochester, Minnesota.
TABLE 2. Standardized mortality ratios for early deaths following acute symptomatic
seizure in Washington Heights, New York City and Rochester, Minnesota
Washington Heights, Rochester,
New York City, Minnesota,
Group SMR (95% CI) SMR (95% CI)
Overall 102.1 (79.3–127.8) 149.1 (119.0–184.7)
Males 120.0 (86.1–159.6) 192.7 (145.2–249.3)
Females 83.2 (54.8–117.6) 105.5 (71.0–148.0)
<65 yr 376.0 (267.2–503.2) 364.6 (252.2–493.1)
≥65 yr 51.6 (34.5–72.1) 1.3 (0.96–1.7)
Etiology
CNS infection 143.1 (61.1–259.5) 73.2 (12.6–175.2)
Brain trauma 39.1 (0.1–153.2) 102.5 (42.5–183.2)
Cerebrovascular disease 81.1 (47.9–122.8) 159.5 (104.1–226.8)
Toxic 149.8 (39.0–332.7) 96.8 (16.7–231.7)
Metabolic 140.7 (83.2–213.2) 184.2 (69.1–337.3)
CNS tumor 26.7 (2.5–76.4) 280.0 (104.5–512.7)
Anoxic encephalopathy 170.5 (90.4–275.8) 1,357.1 (835.5—2,067.3)
Two or more causes NA 222.2 (57.8–499.4)
Systemic 89.9 (23.4–199.6) NA
Unknown cause NA 147.1 (49.8–297.4)
SMR, standardized mortality ratio; CI, confidence interval.
Short-term Mortality
The overall CF was 21.1% in Washington Heights and
19.2% in Rochester. CF did not differ by gender in either
cohort. However, the CF was far greater in the people aged
65 years and older (28.4% in Washington Heights and
40.5% in Rochester) than in younger individuals (17.7%
in Washington Heights and 11.2% in Rochester).
Among the deaths, the most common cause of acute
symptomatic seizure was cerebrovascular disease in both
cohorts (26.4% in Washington Heights and 31.7% in
Rochester; see Table 1). Metabolic cause was also impor-
tant in Washington Heights (26.4%) but not in Rochester
(8.5%). Encephalopathic cause of the acute symptomatic
seizure was also associated with a high proportion of
deaths in both cohorts (19.2% in Washington Heights and
23.2% in Rochester).
We calculated the SMR for early mortality overall and
by age, gender, and etiology (Table 2). In both cohorts,
the SMR was greatly increased overall, and separately for
males, females, and younger individuals. Results differed
for older individuals: the SMR was increased in Washing-
ton Heights (SMR = 51.6, 95% CI 34.5–72.1) but not in
Rochester (SMR = 1.3, 95% CI 0.96–1.7). The SMR was
greatly increased for early death in all etiologies of acute
symptomatic seizure, but most markedly for acute symp-
tomatic seizure due to anoxic encephalopathy (SMR =
170.5 in Washington Heights and 1,357.1 in Rochester).
In the Washington Heights cohort, only the SMR for
brain trauma was not significant (SMR = 39.1, 95% CI
0.1–153.2).
DISCUSSION
We found a 20% CF for deaths during the first 30
days following acute symptomatic seizure. There was no
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difference in CF for males and females, although CF was
greater for older individuals than for individuals younger
than 65 years. This likely reflects the tendency for older
people to die at a higher rate than younger people, regard-
less of their underlying disease process.
Among people with acute symptomatic seizure who die
in the first 30 days, cerebrovascular disease and anoxic
encephalopathy predominate as causes of the seizure.
Metabolic causes of acute symptomatic seizure were com-
monly found among deaths in the Washington Heights co-
hort but not in the Rochester cohort. This may be due to
the differences between the two populations: Washington
Heights is an ethnically diverse population of low socioe-
conomic status with a relatively high prevalence of HIV
infection; and Rochester is an ethnically homogeneous
population (96.7% white non-Hispanic) of middle to high
socioeconomic status with a low prevalence of HIV in-
fection. Interestingly, no deaths occurred during the first
30 days among people with seizures due to eclampsia or
drug/alcohol withdrawal.
Observed deaths greatly exceeded expected deaths
overall and for males, females, young, and old. Addi-
tionally, observed deaths exceeded expected deaths for all
underlying causes of acute symptomatic seizure. These re-
sults are consistent with data on 5-year mortality following
acute symptomatic seizure from Southwest France (1).
The question remains: what, if any, is the contribution
of seizure to the short-term mortality observed following
acute symptomatic seizure? Most of the underlying causes
of acute symptomatic seizure are themselves strongly as-
sociated with death (e.g., cerebrovascular disease, anoxic
encephalopathy, brain trauma, brain neoplasm). The oc-
currence of a seizure during the acute phase of these con-
ditions may be a sign of impending death or an accompa-
niment to severe illness without any effect on mortality.
Studies are needed to unravel these competing explana-
tions for the high mortality in the first 30 days following
acute symptomatic seizure. These studies should follow
individuals with the underlying illness to examine risk
factors for the development of acute symptomatic seizure
and to elucidate risk factors for death among individuals
with acute symptomatic seizure compared to those with-
out such seizures.
REFERENCES
1. Loiseau P, Loiseau J, Picot M-C. One-Year mortality in Bordeaux co-
hort: The value of syndrome classification. Epilepsia 2005;46(suppl.
11):S11–13.
2. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective
population-based epidemiological study of status epilepticus in Rich-
mond, Virginia. Neurology 1996;46:1029–35.
3. Logroscino G, Hesdorffer D, Cascino G, et al. Short-term mortal-
ity after incident status epilepticus. Epilepsia 1997;38(12):1344–
9.
4. Jallon P, Coeytaux A, Galobardes B, et al. Incidence and case-
fatality rate of status epilepticus in the Canton of Geneva. Lancet
1999;353:1496.
5. Vignatelli L, Tonon C, D’Alessandro R. Incidence and short-term
prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia
2003;44:964–8.
6. Knake S, Rosenow F, Vescovi M, et al. Status epilepticus study group
Hessen (SESGH). Incidence of status epilepticus in adults in Ger-
many: a prospective, population-based study. Epilepsia 2001;42:714–
18.
7. Annegers JF, Hauser WA, Lee JR, et al. Incidence of acute symp-
tomatic seizures in Rochester, Minnesota, 1935–1984. Epilepsia
1995;36:327–33.
Epilepsia, Vol. 46, Suppl. 11, 2005
